NCT00099697

Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans

Biologic Effects of DHEA in Humans

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 56 (planned)
• Sponsor: National Institute on Aging (NIA) · NIH
• Sex: All
• Age: 65 Years – 78 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether DHEA replacement therapy decreases abdominal fat and improves insulin sensitivity.

Detailed description

Studies on rats and mice have shown that the adrenal hormone dehydroepiandrosterone (DHEA) reduces abdominal visceral fat and protects against insulin resistance. This study was done to learn if DHEA replacement therapy decreases abdominal obesity and improves insulin action in humans. Participants were randomly assigned to receive 50 mg per day of DHEA or a placebo at bedtime for 6 months. Participants underwent magnetic resonance imaging (MRI) and oral glucose tolerance tests at the beginning and conclusion of the study. Other tests included measurements of hormones and lipids.

Conditions

• Aging
• Obesity
• Insulin Resistance

Interventions

Type	Name	Description
DRUG	DHEA

Timeline

• Start date: 2001-06-01
• Primary completion: 2004-02-01
• Completion: 2004-02-01
• First posted: 2004-12-20
• Last updated: 2009-12-11

Locations

1 site across 1 country: United States